FDA Inspection
Cipla, Ltd.Cipla, Ltd. – FDA Inspection, Mar 20, 2019
Record Details
This FDA Inspection record concerns Cipla, Ltd., with an inspection on March 20, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Angela E. Glenn (Issuing Officer)
- Cheryl A. Clausen
View Company Profile
ID · 764f7c2a-e451-45ce-b59f-335b801752d6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1084973
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cipla, Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 30, 2018 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| December 9, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 1, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cipla, Ltd.
- FDA Inspection 1236690 - 2024-05-08
- FDA Inspection 1073182 - 2018-11-30
- FDA Inspection 997481 - 2016-12-09
- FDA Inspection 882706 - 2014-05-23
- FDA Inspection 755727 - 2011-12-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.